14981102

Source:http://linkedlifedata.com/resource/pubmed/id/14981102

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005684, umls-concept:C0010651, umls-concept:C0017262, umls-concept:C0079419, umls-concept:C0080113, umls-concept:C0185117, umls-concept:C0205210, umls-concept:C0249197, umls-concept:C0288472, umls-concept:C0525037, umls-concept:C0681842, umls-concept:C1274040, umls-concept:C1420626, umls-concept:C2911684
pubmed:issue	6
pubmed:dateCreated	2004-3-15
pubmed:abstractText	To determine whether p53, p21, pRB, and/or p16 expression is associated with bladder cancer stage, progression, and prognosis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14981102-14981108
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma Protein, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AyalaGustavo EGE, pubmed-author:BenedictWilliam FWF, pubmed-author:KimJaHongJ, pubmed-author:LernerSeth PSP, pubmed-author:ShariatShahrokh FSF, pubmed-author:TokunagaHideoH, pubmed-author:ZhouJainHuaJ
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1014-24
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:14981102-Adult, pubmed-meshheading:14981102-Aged, pubmed-meshheading:14981102-Aged, 80 and over, pubmed-meshheading:14981102-Carcinoma, Transitional Cell, pubmed-meshheading:14981102-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:14981102-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:14981102-Cyclins, pubmed-meshheading:14981102-Cystectomy, pubmed-meshheading:14981102-Disease Progression, pubmed-meshheading:14981102-Female, pubmed-meshheading:14981102-Follow-Up Studies, pubmed-meshheading:14981102-Gene Expression Regulation, Neoplastic, pubmed-meshheading:14981102-Humans, pubmed-meshheading:14981102-Male, pubmed-meshheading:14981102-Middle Aged, pubmed-meshheading:14981102-Multivariate Analysis, pubmed-meshheading:14981102-Proportional Hazards Models, pubmed-meshheading:14981102-Retinoblastoma Protein, pubmed-meshheading:14981102-Survival Rate, pubmed-meshheading:14981102-Treatment Outcome, pubmed-meshheading:14981102-Tumor Markers, Biological, pubmed-meshheading:14981102-Tumor Suppressor Protein p53, pubmed-meshheading:14981102-Urinary Bladder Neoplasms
pubmed:year	2004
pubmed:articleTitle	p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
pubmed:affiliation	Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030, USA.
pubmed:publicationType	Journal Article